SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-048710
Filing Date
2014-07-23
Accepted
2014-07-23 19:05:52
Documents
1
Period of Report
2014-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4082
  Complete submission text file 0001209191-14-048710.txt   5662
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882
Aldeyra Therapeutics, Inc. (Issuer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address
Tulipano Stephen J (Reporting) CIK: 0001360548 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36332 | Film No.: 14989737